Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma

Pediatric low-grade gliomas: next biologically driven steps

(2017) David T W Jones et al.   NEURO-ONCOLOGY

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study

(2016) Rahul Krishnatry et al.   CANCER

Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy

(2016) Minh-Phuong Huynh-Le et al.   CHILDS NERVOUS SYSTEM

Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy

(2015) Andrew J. Dodgshun et al.   INTERNATIONAL JOURNAL OF CANCER

Low Grade Gliomas in Children

(2015) Alan Chalil et al.   JOURNAL OF CHILD NEUROLOGY

BRAFMutation andCDKN2ADeletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma

(2015) Matthew Mistry et al.   JOURNAL OF CLINICAL ONCOLOGY

Confirmation of Bevacizumab Activity, and Maintenance of Efficacy in Retreatment After Subsequent Relapse, in Pediatric Low-grade Glioma

(2015) Manas Kalra et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

(2014) Cristiane M. Ida et al.   BRAIN PATHOLOGY

Outcomes of Pediatric Low-grade Gliomas Treated With Radiation Therapy

(2014) Sunil S. Raikar et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

(2014) Q. T. Ostrom et al.   NEURO-ONCOLOGY

Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database

(2014) Pratiti Bandopadhayay et al.   PEDIATRIC BLOOD & CANCER

Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study

(2013) Sridharan Gururangan et al.   NEURO-ONCOLOGY

Radiotherapy in pediatric pilocytic astrocytomas

(2013) K. Müller et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Marked Recovery of Vision in Children With Optic Pathway Gliomas Treated With Bevacizumab

(2013) Robert A. Avery et al.   JAMA Ophthalmology

Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma

(2012) Eric Bouffet et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group

(2012) Joann L. Ater et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas

(2012) Eugene I. Hwang et al.   PEDIATRIC BLOOD & CANCER

Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: Toxicity and efficacy trends

(2012) Marie-Laure Couec et al.   PEDIATRIC BLOOD & CANCER

Irinotecan and bevacizumab in recurrent glioblastoma multiforme

(2011) Jan Nyrop Jakobsen et al.   EXPERT OPINION ON PHARMACOTHERAPY

Primary Neurosurgery for Pediatric Low-Grade Gliomas: A Prospective Multi-Institutional Study From the Children's Oncology Group

(2011) Jeffrey H. Wisoff et al.   NEUROSURGERY

Epidemiology of childhood cancer

(2010) Peter Kaatsch   CANCER TREATMENT REVIEWS

Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas

(2010) Katrin Scheinemann et al.   PEDIATRIC BLOOD & CANCER

Outcome and prognostic features in pediatric gliomas

(2009) Ibrahim Qaddoumi et al.   CANCER

Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma

(2009) Thomas E. Merchant et al.   JOURNAL OF CLINICAL ONCOLOGY

Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan

(2009) Roger J. Packer et al.   PEDIATRIC BLOOD & CANCER

Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors

(2008) Felix Bokstein et al.   CANCER

Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study

(2008) Julia L. Glade Bender et al.   JOURNAL OF CLINICAL ONCOLOGY